Back

Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial

29 August 2017 (08:30 - 08:40)
Organised by:
Congress Presentation Part of: Hot Line: Late-Breaking Clinical Trials 4 Lipids (Epidemiology and Prevention) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Martin Landray

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

12 More presentations in this session

Presentation thumbnail
Discussant review: Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial
Professor J. Chapman (Paris, FR)
Slides Video
Presentation thumbnail
Panel discussion.
Video
Presentation thumbnail
Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY study
Professor H. Itoh (Tokyo, JP)
Slides Video
Presentation thumbnail
Discussant review: Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY study
Professor E. Prescott (Copenhagen, DK)
Slides Video
Presentation thumbnail
Panel discussion.
Video

Access the full session

Session thumbnail
Hot Line: Late-Breaking Clinical Trials 4

The Event

Event poster

ESC Congress 2017

29 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Obicetrapib and cardiovascular events
1 September 2025
thumbnail
Webinar
LDL-C reduction postACS: strike early and strike strong
15 November 2021
thumbnail
Congress Session
Novel mechanisms for insights into atherosclerosis
26 August 2023
thumbnail
Congress Session
Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources